G. Mazzara

发表

Role of Genes That Modulate Host Immune Responses in the Immunogenicity and Pathogenicity of Vaccinia Virus

M. Kuroda, M. Lifton, N. Letvin, 2005, Journal of Virology.

Contribution of hypervariable domains to the conformation of a broadly neutralizing glycoprotein 120 epitope.

C. N. Lee, J. Robinson, M. Essex, 1995, AIDS research and human retroviruses.

Broadly reactive antibody-dependent cellular cytotoxic response to HIV-1 envelope glycoproteins precedes broad neutralizing response in human infection.

R. Koup, J. Sullivan, G. Mazzara, 1991, Viral immunology.

A phase I trial of a recombinant vaccinia virus expressing prostate-specific antigen in advanced prostate cancer.

P. Kantoff, W. Oh, G. Bubley, 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

Mucosal Priming of Simian Immunodeficiency Virus-Specific Cytotoxic T-Lymphocyte Responses in Rhesus Macaques by the Salmonella Type III Secretion Antigen Delivery System

R. Desrosiers, K. Mansfield, J. Lifson, 2003, Journal of Virology.

Cysteine transfer RNA of Escherichia coli: nucleotide sequence and unusual metabolic properties of the 3' C-C-A terminus.

W. McClain, G. Mazzara, 1977, Journal of molecular biology.

Studies of cloned simian immunodeficiency virus-specific T lymphocytes. gag-specific cytotoxic T lymphocytes exhibit a restricted epitope specificity.

R. Young, D. Watkins, N. Letvin, 1990, Journal of immunology.

Recombinant virus vaccine-induced SIV-specific CD8+ cytotoxic T lymphocytes.

N. Letvin, M. D. Miller, G. Mazzara, 1991, Science.

Strategy for monitoring T cell responses to NY-ESO-1 in patients with any HLA class I allele.

V. Cerundolo, L. Old, E. Stockert, 2000, Proceedings of the National Academy of Sciences of the United States of America.

The use of combination vaccinia vaccines and dual-gene vaccinia vaccines to enhance antigen-specific T-cell immunity via T-cell costimulation.

J. Schlom, L. Gritz, J. Kantor, 1999, Vaccine.

The gag-specific cytotoxic T lymphocytes in rhesus monkeys infected with the simian immunodeficiency virus of macaques.

N. Letvin, M. D. Miller, G. Mazzara, 1990, Journal of immunology.

DNA-MVA vaccine protection after X4 SHIV challenge in macaques correlates with day-of-challenge antiviral CD4+ cell-mediated immunity levels and postchallenge preservation of CD4+ T cell memory.

D. Montefiori, K. Mansfield, A. Aldovini, 2008, AIDS research and human retroviruses.

Heterologous Prime/Boost Immunization of Rhesus Monkeys by Using Diverse Poxvirus Vectors

Jenny G. Parvani, D. Montefiori, S. Santra, 2007, Journal of Virology.

Granulocyte/macrophage-colony stimulating factor produced by recombinant avian poxviruses enriches the regional lymph nodes with antigen-presenting cells and acts as an immunoadjuvant.

J. Schlom, J. Greiner, G. Mazzara, 2001, Cancer research.

Immunoadjuvant Lymph Nodes with Antigen-presenting Cells and Acts as an by Recombinant Avian Poxviruses Enriches the Regional Granulocyte / Macrophage-Colony Stimulating Factor Produced Updated

J. Schlom, J. Greiner, G. Mazzara, 2000 .

Analyses of Recombinant Vaccinia and Fowlpox Vaccine Vectors Expressing Transgenes for Two Human Tumor Antigens and Three Human Costimulatory Molecules

J. Schlom, L. Gritz, J. Gulley, 2005, Clinical Cancer Research.

Monitoring CD4+ T cell responses against viral and tumor antigens using T cells as novel target APC.

D. Atanackovic, L. Old, S. Gnjatic, 2003, Journal of immunological methods.

Immunization with lentivirus-like particles elicits a potent SIV-specific recall cytotoxic T-lymphocyte response in rhesus monkeys.

N. Letvin, G. Mazzara, D. Panicali, 1993, AIDS research and human retroviruses.

Generation of hybrid genes and proteins by vaccinia virus-mediated recombination: application to human immunodeficiency virus type 1 env

L. Gritz, G. Mazzara, D. Panicali, 1990, Journal of virology.

A phase I trial of preventive HIV vaccination with heterologous poxviral-vectors containing matching HIV-1 inserts in healthy HIV-uninfected subjects.

D. Montefiori, M. McElrath, P. Goepfert, 2011, Vaccine.

DNA sequence of the transfer RNA region of bacteriophage T4: implications for transfer RNA synthesis.

Guy Plunkett, W. McClain, G. Mazzara, 1981, Proceedings of the National Academy of Sciences of the United States of America.

Gender Differences in Human Immunodeficiency Virus Type 1-Specific CD8 Responses in the Reproductive Tract and Colon following Nasal Peptide Priming and Modified Vaccinia Virus Ankara Boosting

H. Liao, B. Haynes, N. Letvin, 2004, Journal of Virology.

Control of Simian/Human Immunodeficiency Virus Viremia and Disease Progression after IL-2-Augmented DNA-Modified Vaccinia Virus Ankara Nasal Vaccination in Nonhuman Primates1

D. Montefiori, K. Mansfield, A. Aldovini, 2004, The Journal of Immunology.

Two distinct lymphocyte populations mediate simian immunodeficiency virus envelope-specific target cell lysis.

D. Watkins, N. Letvin, L. Gritz, 1990, Journal of immunology.

9 – Maturation Events Leading to Transfer RNA and Ribosomal RNA

Guy Plunkett, W. McClain, G. Mazzara, 1980 .

Searching for clones with open reading frames.

M. Rosbash, G. Mazzara, M. Gray, 1987, Methods in enzymology.

Therapeutic antitumor response after immunization with an admixture of recombinant vaccinia viruses expressing a modified MUC1 gene and the murine T-cell costimulatory molecule B7.

J. Schlom, D. Kufe, L. Gritz, 1997, Journal of immunotherapy.

High levels of anti-human immunodeficiency virus type 1 (HIV-1) memory cytotoxic T-lymphocyte activity and low viral load are associated with lack of disease in HIV-1-infected long-term nonprogressors

C. Rinaldo, Xiao-li Huang, M. Cottrill, 1995, Journal of virology.

The HIV-1 regulatory proteins Tat and Rev are frequently targeted by cytotoxic T lymphocytes derived from HIV-1-infected individuals.

E. Rosenberg, M. Altfeld, B. Walker, 2001, Proceedings of the National Academy of Sciences of the United States of America.

Cross-clade envelope glycoprotein 160-specific CD8+ cytotoxic T lymphocyte responses in early HIV type 1 clade B infection.

H. Sheppard, J. Tartaglia, J. Kunich, 1998, AIDS research and human retroviruses.

Cytotoxic T-lymphocyte cross-reactivity among different human immunodeficiency virus type 1 clades: implications for vaccine development

B. Walker, B. Korber, S. Kalams, 1997, Journal of virology.

Limiting dilution analysis of cytotoxic T lymphocytes to human immunodeficiency virus gag antigens in infected persons: in vitro quantitation of effector cell populations with p17 and p24 specificities

R. Koup, E. Day, D. Brettler, 1991, The Journal of experimental medicine.

High-titer immune responses elicited by recombinant vaccinia virus priming and particle boosting are ineffective in preventing virulent SIV infection.

R. Desrosiers, M. Simon, P. Sehgal, 1994, AIDS research and human retroviruses.

Detection of major histocompatibility complex class I-restricted, HIV-specific cytotoxic T lymphocytes in the blood of infected hemophiliacs.

R. Koup, D. Brettler, P. Levine, 1989, Blood.

Identification of Multiple Simian Immunodeficiency Virus (SIV)-Specific CTL Epitopes in Sooty Mangabeys with Natural and Experimentally Acquired SIV Infection1

R. Johnson, L. Gritz, G. Mazzara, 2000, The Journal of Immunology.

and Experimentally Acquired SIV Infection Epitopes in Sooty Mangabeys with Natural Immunodeficiency Virus (SIV)-Specific CTL Identification of Multiple Simian

R. Johnson, L. Gritz, G. Mazzara, 1999 .

Antigenic specificity of antibody-dependent cell-mediated cytotoxicity directed against human immunodeficiency virus in antibody-positive sera

R. Koup, P. Levine, J. Sullivan, 1989, Journal of virology.

An SHIV DNA/MVA rectal vaccination in macaques provides systemic and mucosal virus-specific responses and protection against AIDS.

K. Mansfield, R. Johnson, M. Piatak, 2004, AIDS research and human retroviruses.

Generation and analysis of vaccinia virus recombinants.

A. Mahr, G. Mazzara, A. Destree, 1993, Methods in enzymology.

HIV-1 gag-specific cytotoxic T lymphocytes recognize multiple highly conserved epitopes. Fine specificity of the gag-specific response defined by using unstimulated peripheral blood mononuclear cells and cloned effector cells.

B. Walker, A. Trocha, R. Johnson, 1991, Journal of immunology.

Nucleotide sequence of an arginine transfer ribonucleic acid from bacteriophage T4.

J. Seidman, W. McClain, G. Mazzara, 1977, The Journal of biological chemistry.

Characterization of bacteriophage T4 and D RNA, a low-molecular-weight RNA of unknown function.

Guy Plunkett, W. McClain, G. Mazzara, 1981, Archives of biochemistry and biophysics.

Prior DNA immunization enhances immune response to dominant and subdominant viral epitopes induced by a fowlpox-based SIVmac vaccine in long-term slow-progressor macaques infected with SIVmac251.

D. Venzon, E. Tryniszewska, G. Franchini, 2003, Virology.

Neutralizing antibody-independent containment of immunodeficiency virus challenges by DNA priming and recombinant pox virus booster immunizations

D. Montefiori, J. Lifson, R. Johnson, 1999, Nature Medicine.

Use of recombinant poxviruses to stimulate anti-melanoma T cell reactivity

F. Marincola, S. Rosenberg, L. Gritz, 2006, Annals of Surgical Oncology.

Use of lentivirus-like particles alone and in combination with live vaccinia-virus-based vaccines.

G. Mazzara, R. Hesselton, E. J. Stott, 1992, AIDS research and human retroviruses.